[{"address1": "20 Commerce Drive", "address2": "Suite 135", "city": "Cranford", "state": "NJ", "zip": "07016", "country": "United States", "phone": "732 980 4500", "website": "https://enzon.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard L. Feinstein CPA", "age": 81, "title": "CEO, CFO & Secretary", "yearBorn": 1943, "fiscalYear": 2024, "totalPay": 226925, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.1, "open": 0.0955, "dayLow": 0.0939, "dayHigh": 0.0955, "regularMarketPreviousClose": 0.1, "regularMarketOpen": 0.0955, "regularMarketDayLow": 0.0939, "regularMarketDayHigh": 0.0955, "exDividendDate": 1569801600, "payoutRatio": 0.0, "beta": 0.239, "volume": 11595, "regularMarketVolume": 11595, "averageVolume": 49544, "averageVolume10days": 104220, "averageDailyVolume10Day": 104220, "bid": 0.087, "ask": 0.1099, "bidSize": 10000, "askSize": 35000, "marketCap": 7421460, "fiftyTwoWeekLow": 0.06, "fiftyTwoWeekHigh": 0.24, "priceToSalesTrailing12Months": 285.44077, "fiftyDayAverage": 0.0926, "twoHundredDayAverage": 0.1105, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 7473254, "profitMargins": -2.53846, "floatShares": 30114059, "sharesOutstanding": 74214600, "sharesShort": 259381, "sharesShortPriorMonth": 298381, "sharesShortPreviousMonthDate": 1460678400, "dateShortInterest": 1463097600, "sharesPercentSharesOut": 0.0058999998, "heldPercentInsiders": 0.108389996, "heldPercentInstitutions": 0.48584, "shortRatio": 1.71, "shortPercentOfFloat": 0.0068, "impliedSharesOutstanding": 74214600, "bookValue": 0.026, "priceToBook": 3.8461537, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -1341000, "trailingEps": -0.02, "enterpriseToRevenue": 287.433, "52WeekChange": -0.3333333, "SandP52WeekChange": 0.1116153, "lastDividendValue": 0.12, "lastDividendDate": 1569801600, "quoteType": "EQUITY", "currentPrice": 0.1, "recommendationKey": "none", "totalCash": 44966000, "totalCashPerShare": 0.606, "totalDebt": 0, "quickRatio": 81.166, "currentRatio": 82.168, "totalRevenue": 26000, "revenuePerShare": 0.0, "returnOnAssets": -0.02711, "returnOnEquity": -0.00145, "grossProfits": 26000, "freeCashflow": -1292875, "operatingCashflow": 253000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -77.03846, "financialCurrency": "USD", "symbol": "ENZN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.1, "shortName": "Enzon Pharmaceuticals, Inc.", "longName": "Enzon Pharmaceuticals, Inc.", "marketState": "CLOSED", "cryptoTradeable": false, "firstTradeDateMilliseconds": 445703400000, "regularMarketChange": 0.0, "regularMarketDayRange": "0.0939 - 0.0955", "fullExchangeName": "OTC Markets OTCQX", "averageDailyVolume3Month": 49544, "fiftyTwoWeekLowChange": 0.040000003, "fiftyTwoWeekLowChangePercent": 0.66666675, "fiftyTwoWeekRange": "0.06 - 0.24", "fiftyTwoWeekHighChange": -0.13999999, "fiftyTwoWeekHighChangePercent": -0.5833333, "fiftyTwoWeekChangePercent": -33.333332, "dividendDate": 1571097600, "earningsTimestamp": 1746820800, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.02, "fiftyDayAverageChange": 0.0073999986, "fiftyDayAverageChangePercent": 0.07991359, "twoHundredDayAverageChange": -0.010499999, "twoHundredDayAverageChangePercent": -0.09502261, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "hasPrePostMarketData": false, "corporateActions": [], "regularMarketTime": 1752264000, "exchange": "OQX", "messageBoardId": "finmb_269599", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Enzon Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-07-12"}]